Biotech Capital Limited announced that it has appointed Dr. Rocco Iannello as Group Business Development Director in its Melbourne office, to lead the marketing of the group's services and capabilities to a growing number of local and international clients. He has over 25 years experience in biomedical research, business development, technology commercialization and industry/government engagement. Between 2002 and 2015 he held senior executive business development positions at Monash Commercial and Monash Institute of Pharmaceutical Sciences. He has held directorships with a number of industry organizations and biotech start-up companies and brings to the role an extensive global network in the biotech and pharmaceutical industries.